Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF);Importancia del test de sobrecarga oral a la glucosa (TSOG) en una consulta específica de IRC avanzada estadio IV y V

Nefrologia

Volumn 27, Issue 1, 2007, Pages 30-37

  Rufino Hernández, Margarita ^a   Barbero, P ^a   Hernandez D ^a   Torres, A ^a   Lorenzo, V ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Chronic renal failure; Diabetes; Insulin resistance; Oral glucose tolerance test

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 34447094970     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Eschwége E, Richard J.L, Thibult N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res (Supl. 15): 41-46, 1985.
2. Despres J.P, Lamarche B, Mauriege P, Cantin B, Dogenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957, 1996.
3. Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Stroke 29: 1860-1866, 1998.
4. Bokyo EJ, Chitson P, De Courten M, Tuomilehto P, Zimmet PZ, Alberti K. Features of the metabolic syndrome predicts higher risk of diabetes and impaired glucose tolerance. A prospective study in Mauritius. Diabetes Care 9: 1242-1248, 2000.
5. Lillioja S, Mott D, Spraul M, Ferraro R, Foley J, Ravussin E, Knowler W, Bennett P, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. N Engl J Med 329: 1988-1992, 1993.
6. Rigalleau V, Gin H. Carbohydrate metabolism in uraemia. Curr Opin Clin Nutr Metab Care 8: 463-9, 2005.
7. Dimitrakov D, Kumchev E, Chichovska M, Lyutakova E. On the disturbances in carbohydrate metabolism in pre-dialysis patients with chronic renal failure. Folia Med 40: 76-82, 1998.
8. A Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 51: 1226-32, 2002.
9. Mark J. Sarnak, MD, Cochair; Andrew S. Levey, MD, Cochair; Anton C. Schoolwerth, MD, Cochair; Josef Coresh, MD, PhD; Bruce Culleton, MD; L. Lee Hamm, MD; Peter A. McCullough, MD, MPH; Bertram L. Kasiske, MD; Ellie Kelepouris, MD; Michael J. Klag, MD, MPH; Patrick Parfrey, MD; Marc Pfeffer, MD, PhD; Leopoldo Raij, MD; David J. Spinosa, MD; Peter W. Wilson, MD. A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. Circulation 108: 2154, 2003.
10. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as marker of cardiovascular risk hypertensive patients. Hypertension 33: 1111-1117, 1999.
11. Van Popele NM, Grobbee DE, Bots ML. Association between arterial stiffness and atherosclerosis (The Rotterdam Study). Stroke 32: 454-460, 2001.
12. P Almirall J, Vaqueiro M, Antón E, Bare ML, González V, Jaimez E, Gimeno C: Centros de Asistencia Primaria (Grupo del Proyecto «DÀVIS»). Prevalence of chronic kidney disease in community-dwelling elderly and associated cardiovascular risk factors. Nefrología 25 (6): 655-62, 2005.
13. The Expert Committee on the diagnosis and classification of Diabetes Mellitus. Follow up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167, 2003.
14. The Expert Committee on the diagnosis and classification of Diabetes Mellitus Report of the Expert Committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197, 1997.
15. Matthews D.R, Hosker JP, Rudenski AS, Taylor BA, Teacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man. Diabetologí a 28: 412-419, 1985.
16. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Cuantificación de insulinorresistencia con los valores de insulina basal e índice HOMA en una población no diabética. Med Clin (Barc) 117: 530-533, 2001.
17. Bonora E, Targher G, Alberiche M, Bonnadona R, Saggiani S, Zenere M, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23: 57-63, 2000.
18. Katsuki A, Sumida Y, Gabazza E.C, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicador of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24: 460-464, 2001.
19. Masanori Emoto, Yoshiki Nishizawa, Kiyoshi Maekawa, Yoshikazu Hiura, Hiroyuki Kanda, Takahiko Kawagishi, Tetsuo Shoji, Yasuhisa Okuno, Hirotoshi Morii. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22: 818-822, 1999.
20. McAuley K, Williams S, Mann J, Walker R, Lewis-Barned N, Temple L, Duncan A. Diagnosing insulin resistance in the general population. Diabetes Care 24: 460-464, 2001.
21. Tetsuo Shoji, Masanori Emoto, Yoshiki Nishizawa. HOMA Index to assess insulin resistance in renal failure patients. Nephron 89: 348-349, 2000.
22. Kashiwabara H, Inaba M, Maruno Y, Morita T, Awata T, Negishi K, Litaka M, Katayama S. Insulin levels during fasting and the glucose tolerance test and HOMA's index predict subsequent development of hypertension. J Hypertens 18: 83-88, 2000.
23. McLaughlin T, Abbasi F, Cheal K, Chuc Lamendola, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139: 802-809, 2003.
24. Álvarez Cosmea A, López Fernández V, Suárez García S, Arias García T, Prieto Díaz MA, Díaz González L. Differences in the prevalence of metabolic syndrome according to the ATPIII and WHO definitions. Med Clin (Barc) 19; 124 (10): 368-70, 2005.
25. The DECODE Study Group, the European Diabetes Epidemiology Group: Glucosa tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Me 161: 397-404, 2001.
26. Simmons D, Thompson CF, Engelgau MM. Controlling the diabetes epidemic: how should we screen for undiagnosed diabetes and dysglycaemia? Diabet Med 22 (2): 207-12, 2005.
27. Botas P, Delgado E, Castano G, Díaz de Grenu C, Prieto J, Díaz-Cadorniga FJ. Comparison of the diagnostic criteria for diabetes mellitus, WHO-1985, ADA-1997 and WHO-1999 in the adult population of Asturias (Spain). Diabet Med 20 (11): 904-8, 2003.
28. De Pablos Velasco PL, Martínez Martín FJ, Rodríguez Pérez F, Anía BJ, Losada A y Betancor P. Prevalence and determinants of diabetes mellitas and glucosa intolerante in a Canarian Caucasian population-comparison of the 1997 ADA and 1985 WHO criteria. The Guía Study. Diabetc Medicine 18: 235-241, 2001.
29. Lorenzo V, y Martín Urcuyo B. Análisis epidemioló gico del incremento de insuficiencia renal terminal asociada a diabetes mellitas tipo 2. Nefrología 20: 77-81, 2000.
30. Chen J, Mentner P, Lee Hamm L, Fonseca V, Batuman V, Whelton P He J. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14: 469-477, 2003.
31. Aiko PJ, De Vries Ap, Bakker SJ, Van Son WJ, Homan van der Heide JJ, The TH, De Jong PE, Gans RO. Insulin resistance as putative cause of chronic renal transplant dysfunction. Am J Kidney Dis 41: 859-67, 2003
32. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53: 1343-7, 1998.
33. Carolina S. Fox, Martin G larson, Eric P. Leip, James B. Meigs, Peter WF. Wilson, Daniel Levy. Glycemic status and development of Kidney Disease. Diabetes Care 28: 2436-2440, 2005.
34. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13: 1894-1900, 2002.
35. Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetología 39: 1345-1350, 1996.
36. Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven G. Relationship between obesity, insulin resistance and coronary heart disease risk. J Am Coll Cardiol 40: 937-943, 2002.
37. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimot Y, Kishimoto K, Ishimura E, Tabata T, Nizishawa Y. Diabetes mellitus, aortic stiffness and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 12: 2117-2124, 2001.
38. Novoa F, Boronat M, Saavedra P, Díaz-Cremades J, Varillas V, La Roche F, Alberiche M, Carrillo A. Differences in cardiovascular risk factors, insulin resistance and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation. Diabetes Care 28: 2388-2393, 2005.
39. Blake DR, Meigs JB, Muller DC, Najjar SS, Andrés R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53: 2095-2100, 2005.
40. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93: 1809-1817, 1996.
41. Ohya Y, Iseki K, Iseki C, Miyagi T, Kinjo K, Takishita S. Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis 47(5): 790-7, 2006.